DIR fee — Lanton Law Blog

Lanton Law Talks with Savages Drug About The Business of Pharmacy

We speak with Deb Rockwell; Business Manager at Savages’ Drug in Fairfield, Maine about the importance of understanding pharmacy accounts receivable.

healthcare, pharmacy, pharmacy benefit manager, PSAORon LantonAugust 1, 2022pharmacy, Savages' Drug, accounts receivable, finance, margins, Maine, Lanton Law, DIR fee

NCPA Files Lawsuit on Pharmacy Direct & Indirect Remuneration (DIR) Fees

The National Community Pharmacists Association (NCPA) has filed a lawsuit against the U.S. Department of Health & Human Services (HHS) on DIR fees. Specifically, the complaint seeking declaratory and injunctive relief seeks three things according to NCPA’s release:

pharmacy, pharmaceuticals, pharmacy benefit manager, Medicare, Medicare Part D, lawsuits, healthcare, insurance, HHSRon LantonJune 7, 2021Pharmacy, U.S. Department of Health & Human Services, DIR fee, direct and indirect remuneration fees, HHS, federal court, law, lawsuit

Lanton Law Interviews the Massachusetts Pharmacists Association on DIR & Provider Status

We are excited to have Lindsay De Santis; Executive Vice President of the Massachusetts Pharmacists Association (MPhA) do a blogcast with us. Our conversation covers pharmacy DIR (direct and indirect remuneration) fees, pharmacy provider status and COVID-19.